Title of cohort

    Personality and Total Health (PATH) Through Life (20s Cohort)

    Acronym for cohort

    PATH 20s

    Name of Principal Investigator - Title

    Prof

    Name of Principal Investigator - First name

    Kaarin

    Name of Principal Investigator - Last name

    Anstey

    Address of institution -Institution

    The Australian National University, Centre for Research on Ageing, Health and Wellbeing

    Address of institution - Street address

    Florey Building, 54 Mills Rd, ACTON

    Address of institution - City

    Canberra

    Address of institution - Postcode

    2601

    Country

    Austrailia

    Funding source

    National Health and Medical Research Council

    Q1a. Please indicate below if your cohort includes or expects to include, incidence of the following conditions?

    Neurodegenerative disease in general

    Q1b. When are studies on the above condition(s) expected to become possible?

    Already possible

    Q2a. In a single sentence what is the stated aim of the cohort?

    To track and define the course of depression, anxiety, substance use and cognitive ability, identify environmental risk and protective factors within these domains, and examine the relationships between depression, anxiety and substance use with cognitive ability and dementia from early to mid adulthood.

    Q2b. What distinguishes this cohort from other population cohorts?

    Narrow age cohort followed up over a long amount of time with data enhanced by substudies including physical and genetic testing and neuroimaging

    Q3a. i) Number of publications that involve use of your cohort to date

    Q3a.ii) Please give up to three examples of studies to date (Principal Investigator, Institution, Title of Study)

    Q3b. If data on research outputs are already available please paste the publication list/other data or provide a link to where these data are publicly available

    http://crahw.anu.edu.au/research/projects/personality-total-health-path-through-life/published-papers

    Q3c. If no research has been done as yet, please explain in a few sentences what information (i.e. research findings) you expect will be gained from the population

    Q4a. Study criteria: what is the age range of participants at recruitment? Age in years From:

    20

    Q4a. Study criteria: what is the age range of participants at recruitment? To:

    24

    Q4b. Study criteria: what are the inclusion criteria?

    Registered on the Australian Electoral Roll in the ACT or Queanbeyan (NSW) and aged between 20-24 years at recruitment

    Q4c. Study criteria: what are the exclusion criteria?

    Out of age range for this cohort (<20 & >24)

    Q5. What is the size of the cohort (i.e. how many participants have enrolled)?

    1,000-5,000 participants

    Q6a. Please describe what measures are used to characterise participants

    Demographics, lifestyle, mental health and psychological scales, cognitive and physical tests

    Q6b. Are there additional measures for participants with a clinical disorder?

    Q6c. Are there defined primary and secondary endpoints (e.g. defined health parameters)?

    No

    If yes please specify

    Q7. What is the study design (select all that apply)?

    Longitudinal| Prospective cohort

    Q8. Are your cases matched by

    Age

    Q9a. Does your study include a specialised subset of control participants?

    No

    Q9b. If your study includes a specialised subset of control participants please describe

    Q10a. i) Please enter the data collection start date

    01/01/1999

    Q10a. ii) Please enter the data collection end date

    01/01/2019

    Q10a. iii) Is data collection for this study

    Data collection ongoing| Data analysis ongoing| Closed to new patients

    Q10b. If data collection is ongoing, are there plans to continue the cohort study beyond the current projected end date?

    Q11. Is data collected

    Through the study and by links to medical records

    Other please specify here

    Q12. Is there a system in place to enable re-contact with patients to ask about participation in future studies?

    Yes (participants given permission to be re-contacted via PIs)

    Q13a. Please give information on the format and availability of data stored in a database (1)

    Data summarised in database

    % available

    100

    Q13a. Please give information on the format and availability of data stored in a database (2)

    No

    % available

    Q13a. Please give information on the format and availability of data stored in a database (3)

    Database on spreadsheet (e.g. excel)

    % available

    100

    Q13a. Please give information on the format and availability of data stored in a database (4)

    No

    % available

    Other (please specify)

    % available

    Q13b. Please give information on the format and availability of data held as individual records (1)

    Data is held as individual records

    % available

    100

    Q13b. Please give information on the format and availability of data held as individual records (2)

    No

    % available

    Q13b. Please give information on the format and availability of data held as individual records (3)

    Data held on computer based records

    % available

    100

    Q13b. Please give information on the format and availability of data held as individual records (4)

    No

    % available

    Please specify language used

    English

    Q14a. Is data available to other groups?

    Yes

    Q14b. If data is available to other groups what is the access policy/mechanisms for access?

    Apply to PI or co-ordinator at resource| Access committee mechanism

    Q15. What data sharing policy is specified as a condition of use?

    No requirement to make data publicly available

    Q16a. Are tissues/samples/DNA available to other groups?

    No

    Q16b i) If yes, please describe below:

    Q16b. ii) In what form are tissues/samples/DNA supplied?

    Q16b. iii) Is the access policy/mechanism for obtaining samples the same as that for obtaining data (Q14 above)?

    Q17. Is information on biological characteristics available to other groups?

    Yes, for all the cohort

    Number of Patients

    % of total cohort

Types: Population Cohorts
Member States: Australia
Diseases: Neurodegenerative disease in general
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF